Elevated 4-aminobiphenyl and 2,6-dimethylaniline hemoglobin adducts and increased risk of bladder cancer among lifelong nonsmokers-the shanghai bladder cancer study

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 5, 2013, Pages 937-945

  Tao, Li ^a   Day, Billy W ^b   Hu, Bibin ^b   Xiang, Yong Bing ^e   Wang, Renwei ^d   Stern, Mariana C ^f   Gago Dominguez, Manuela ^f,g   Cortessis, Victoria K ^f   Conti, David V ^f   Van Den Berg, David ^f   Pike, Malcolm C ^f,h   Gao, Yu Tang ^e   Yu, Mimi C ^f   Yuan, Jian Min ^c,d  

^a CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^e SHANGHAI JIAO TONG UNIVERSITY   (China)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^h MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,6 DIMETHYLANILINE; 4 BIPHENYLAMINE; BIOLOGICAL MARKER; COTININE; HEMOGLOBIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLOOD DONOR; CANCER RISK; CELL LYSATE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; URINALYSIS;

AGED; ANILINE COMPOUNDS; CASE-CONTROL STUDIES; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SMOKING; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84877956751     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-1447     Document Type: Article

References (34)

1. IARC. Chemical agents and related occupations. IARC Monogr Eval Carcinog Risks Hum 2012;100:9-562.
2. Bryant MS, Skipper PL, Tannenbaum SR, Maclure M. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res 1987;47:602-8.
3. Silverman DT, Devesa SS, Moore LL, Rothman N. Bladder cancer. In: Schottenfeld D, Fraumeni JJ, editors. Cancer epidemiology and prevention. New York: Oxford University Press; 2006. p. 1101-27.
4. Skipper PL, Tannenbaum SR, Ross RK, Yu MC. Nonsmoking-related arylamine exposure and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2003;12:503-7.
5. Castelao JE, Yuan JM, Skipper PL, Tannenbaum SR, Gago-Dominguez M, Crowder JS, et al. Gender-and smoking-related bladder cancer risk. J Natl Cancer Inst 2001;93:538-45.
6. Jiang X, Yuan JM, Skipper PL, Tannenbaum SR, Yu MC. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County. Cancer Res 2007;67:7540-5.
7. Tao L, Xiang YB, Wang R, Nelson HH, Gao YT, Chan KK, et al. Environmental tobacco smoke in relation to bladder cancer risk-the Shanghai bladder cancer study [corrected]. Cancer Epidemiol Biomarkers Prev 2010;19:3087-95.
8. U. S. National Toxicology Program. Toxicology and carcinogenesis studies of 2,6-xylidine (2,6-dimethylaniline) (CAS No. 87-62-7) in Charles River CD rats (Feed Studies). Technical Report Series No. 278. Research Triangle Park, NC: National Toxicology Program; 1990. 2,6-Dimethylaniline (2,6-xylidine). IARC Monogr Eval Carcinog Risks Hum 1993;57:323-35.
9. IARC. Monographs on the evaluation of carcinogenic risks to humans. Tobacco smoke and involuntary smoking. Vol. 83. Lyon, France: World Health Organization-International Agency for Research on Cancer; 2004.
10. Hecht SS. Tobacco carcinogens, their biomarkers and tobaccoinduced cancer. Nat Rev Cancer 2003;3:733-44.
11. Gan J, Skipper PL, Gago-Dominguez M, Arakawa K, Ross RK, Yu MC, et al. Alkylaniline-hemoglobin adducts and risk of nonsmoking-related bladder cancer. J Natl Cancer Inst 2004;96: 1425-31.
12. Yu MC, Skipper PL, Tannenbaum SR, Chan KK, Ross RK. Arylamine exposures and bladder cancer risk. Mutat Res 2002;506-507: 21-8.
13. Bryant MS, Vineis P, Skipper PL, Tannenbaum SR. Hemoglobin adducts of aromatic amines: Associations with smoking status and type of tobacco. Proc Natl Acad Sci U S A 1988;85: 9788-91.
14. Skipper PL. Precision and sensitivity of aminobiphenyl hemoglobin adduct assays in a long-term population study. J Chromatogr B Analyt Technol Biomed Life Sci 2002;778:375-81.
15. Skarping G, Willers S, Dalene M. Determination of cotinine in urine using glass capillary gas chromatography and selective detection, with special reference to the biological monitoring of passive smoking. J Chromatogr 1988;454:293-301.
16. Patrianakos C, Hoffmann D. Chemical studies on tobacco smoke. LXIV. On the analysis of aromatic amines in cigarette smoke. J Anal Toxicol 1979;3:150-4.
17. Hoffmann D, Djordjevic MV, Hoffmann I. The changing cigarette. Prev Med 1997;26:427-34.
18. Wu W, Zhang L, Jain RB, Ashley DL, Watson CH. Determination of carcinogenic tobacco-specific nitrosamines in mainstream smoke from U.S.-brand and non-U.S.-brand cigarettes from 14 countries. Nicotine Tob Res 2005;7:443-51.
19. Yu MC, Skipper PL, Taghizadeh K, Tannenbaum SR, Chan KK, Henderson BE, et al. Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California. J Natl Cancer Inst 1994;86: 712-6.
20. Tokiwa H, Nakagawa R, Horikawa K. Mutagenic/carcinogenic agents in indoor pollutants; the dinitropyrenes generated by kerosene heaters and fuel gas and liquefied petroleum gas burners. Mutat Res 1985; 157:39-47.
21. Paputa-Peck MC, Marano RS, Schuetzle D, Riley TL, Hampton CV, Prater TJ, et al. Determination of nitrated polynuclear aromatic hydrocarbons in particulate extracts by capillary column gas chromatography with nitrogen selective detection. Anal Chem 1983;55: 1946-54.
22. Suzuki J, Meguro S, Morita O, Hirayama S, Suzuki S. Comparison of in vivo binding of aromatic nitro and amino compounds to rat hemoglobin. Biochem Pharmacol 1989;38:3511-9.
23. Chiang TA, Wu PF, Ko YC. Identification of carcinogens in cooking oil fumes. Environ Res 1999;81:18-22.
24. Turesky RJ, Freeman JP, Holland RD, Nestorick DM, Miller DW, Ratnasinghe DL, et al. Identification of aminobiphenyl derivatives in commercial hair dyes. Chem Res Toxicol 2003;16:1162-73.
25. Gago-Dominguez M, Castelao JE, Yuan JM, Yu MC, Ross RK. Use of permanent hair dyes and bladder-cancer risk. Int J Cancer 2001;91: 575-9.
26. IARC. Monographs on the evaluation of carcinogenic risks to humans Occupational exposures of hairdressers and barbers and personal use of hair colourants. Some hair dyes, cosmetic colourants, industrial dyestuffs and aromatic amines. Vol. 57. Lyon, France: IARC; 1997.
27. Short CR, Joseph M, Hardy ML. Covalent binding of [14C]-2,6- dimethylaniline to DNA of rat liver and ethmoid turbinate. J Toxicol Environ Health 1989;27:85-94.
28. Skipper PL, Trudel LJ, Kensler TW, Groopman JD, Egner PA, Liberman RG, et al. DNA adduct formation by 2,6-dimethyl-, 3,5-dimethyl-, and 3-ethylaniline in vivo in mice. Chem Res Toxicol 2006;19:1086-90.
29. Bryant MS, Simmons HF, Harrell RE, Hinson JA. 2,6-Dimethylaniline- hemoglobin adducts from lidocaine in humans. Carcinogenesis 1994;15:2287-90.
30. Parker RJ, Collins JM, Strong JM. Identification of 2,6-xylidine as a major lidocaine metabolite in human liver slices. Drug Metab Dispos 1996;24:1167-73.
31. Putter J, Sagner G. Chemical studies to detect residues of xylazine hydrochloride. Vet Med Rev 1973;2:145-59.
32. Su Y, Mitchell SH, Mac AntSaoir S. Carbendazim and metalaxyl residues in post-harvest treated apples. Food Addit Contam 2003; 20:720-7.
33. PMR Agency. Established maximum residue limit-Metalaxyl. In: EMRL2008-21 & 33. Ottawa, Ontario, Canada: The Health Canada Pest Management Regulatory Agency; 2008.
34. DEFRA. The pesticides (maximum residue levels in crops, food and feeding stuffs) (England and Wales) (Amendment) (No. 2), Regulations 2002. No. 2723, London, England: HMSO; 2002.